Skip to content

Clinical trials

Phase 3 Carcinoma, Hepatocellular trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 3 Country / region: Belgium Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20082
20091
20103
20111
20122
20133
20141
20152
20171
20182
20193
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting5
Terminated5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
Bristol-Myers Squibb3
Eli Lilly and Company2
Exelixis2
Hoffmann-La Roche2
Abbott1
AstraZeneca1
Boston Scientific Corporation1
Daiichi Sankyo1
Eisai Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular25
Liver Neoplasms7
Carcinoma4
Neoplasms4
Adenocarcinoma1
Digestive System Diseases1
Digestive System Neoplasms1
Hepatoblastoma1
Liver Diseases1
Neoplasms by Histologic Type1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.